TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling

被引:111
作者
Oida, Takatoku
Xu, Lili
Weiner, Howard L.
Kitahi, Atsushi
Strober, Warren
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH,Clin Res Ctr, Bethesda, MD 20892 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.177.4.2331
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) T cells play a pivotal role in immunological homeostasis by their capacity to exert immunosuppressive activity. However, the mechanism by which these cells function is still a subject for debate. We previously reported that surface (membrane) TGF-beta produced by CD4(+)CD25(+) T cells was an effector molecule mediating suppressor function. We now support this finding by imaging surface TGF-beta on Foxp3(+)CD4(+)CD25(+) T cells in confocal fluorescence microscopy. Then, using a TGF-beta-sensitive mink lung epithelial cell (luciferase) reporter system, we show that surface TGF-beta can be activated to signal upon cell-cell contact. Moreover, if such TGF-beta signaling is blocked in an in vitro assay of CD4(+)CD25(+) T cell suppression by a specific inhibitor of TGF-beta RI, suppressor function is also blocked. Finally, we address the role of CTLA-4 in CD4(+)CD25(+) T cell suppression, showing first that whereas anti-CTLA-4 does not block in vitro suppressor function, it does complement the blocking activity of anti-TGF-beta. We then show with confocal fluorescence microscopy that incubation of CD4(+)CD25(+) T cells with anti-CTLA-4- and rB7-1/Fc-coated beads results in accumulation of TGF-beta at the cell-bead contact site. This suggests that CTLA-4 signaling facilitates TGF-beta-mediated suppression by intensifying the TGF-beta signal at the point of suppressor cell-target cell interaction.
引用
收藏
页码:2331 / 2339
页数:9
相关论文
共 39 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes [J].
Annunziato, F ;
Cosmi, L ;
Liotta, F ;
Lazzeri, E ;
Manetti, R ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Romagnani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :379-387
[3]  
Azuma T, 2003, CANCER RES, V63, P4516
[4]   TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[5]   Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5) [J].
Callahan, JF ;
Burgess, JL ;
Fornwald, JA ;
Gaster, LM ;
Harling, JD ;
Harrington, FP ;
Heer, J ;
Kwon, C ;
Lehr, R ;
Mathur, A ;
Olson, BA ;
Weinstock, J ;
Laping, NJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (05) :999-1001
[6]  
Chai JG, 2002, EUR J IMMUNOL, V32, P2365, DOI 10.1002/1521-4141(200208)32:8<2365::AID-IMMU2365>3.0.CO
[7]  
2-2
[8]   Requirement for transforming growth factor β1 in controlling T cell apoptosis [J].
Chen, WJ ;
Jin, WW ;
Tian, HS ;
Sicurello, P ;
Frank, M ;
Orenstein, JM ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :439-453
[9]  
CHRIST M, 1994, J IMMUNOL, V153, P1936
[10]   Evidence that furin is an authentic transforming growth factor-β1-converting enzyme [J].
Dubois, CM ;
Blanchette, F ;
Laprise, MH ;
Leduc, R ;
Grondin, F ;
Seidah, NG .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :305-316